These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 15183240)

  • 1. Risk factors and clinical outcomes of nosocomial multi-drug resistant Pseudomonas aeruginosa infections.
    Cao B; Wang H; Sun H; Zhu Y; Chen M
    J Hosp Infect; 2004 Jun; 57(2):112-8. PubMed ID: 15183240
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Risk factors and clinical outcomes of nosocomial infections caused by multidrug resistant Pseudomonas aeruginosa].
    Cao B; Wang H; Zhu YJ; Chen MJ
    Zhonghua Jie He He Hu Xi Za Zhi; 2004 Jan; 27(1):31-5. PubMed ID: 14989823
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Investigation of a nosocomial outbreak by alginate-producing pan-antibiotic-resistant Pseudomonas aeruginosa.
    Yakupogullari Y; Otlu B; Dogukan M; Gursoy C; Korkmaz E; Kizirgil A; Ozden M; Durmaz R
    Am J Infect Control; 2008 Dec; 36(10):e13-8. PubMed ID: 19084158
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical, microbiologic, and epidemiologic characteristics of Pseudomonas aeruginosa infections in a University Hospital, Malatya, Turkey.
    Yetkin G; Otlu B; Cicek A; Kuzucu C; Durmaz R
    Am J Infect Control; 2006 May; 34(4):188-92. PubMed ID: 16679175
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk factors for imipenem-resistant Pseudomonas aeruginosa: a comparative analysis of two case-control studies in hospitalized patients.
    Zavascki AP; Cruz RP; Goldani LZ
    J Hosp Infect; 2005 Feb; 59(2):96-101. PubMed ID: 15620442
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Imipenem-resistant Pseudomonas aeruginosa gastrointestinal carriage among hospitalized patients: risk factors and resistance mechanisms.
    Lepelletier D; Cady A; Caroff N; Marraillac J; Reynaud A; Lucet JC; Corvec S
    Diagn Microbiol Infect Dis; 2010 Jan; 66(1):1-6. PubMed ID: 19775845
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pan-drug-resistant Pseudomonas aeruginosa causing nosocomial infection at a university hospital in Taiwan.
    Hsueh PR; Tseng SP; Teng LJ; Ho SW
    Clin Microbiol Infect; 2005 Aug; 11(8):670-3. PubMed ID: 16008621
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factors for imipenem-resistant Pseudomonas aeruginosa among hospitalized patients.
    Harris AD; Smith D; Johnson JA; Bradham DD; Roghmann MC
    Clin Infect Dis; 2002 Feb; 34(3):340-5. PubMed ID: 11774081
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outbreak of carbapenem-resistant Pseudomonas aeruginosa infection in a surgical intensive care unit.
    Kohlenberg A; Weitzel-Kage D; van der Linden P; Sohr D; Vögeler S; Kola A; Halle E; Rüden H; Weist K
    J Hosp Infect; 2010 Apr; 74(4):350-7. PubMed ID: 20170982
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nosocomial colonization due to imipenem-resistant Pseudomonas aeruginosa epidemiologically linked to breast milk feeding in a neonatal intensive care unit.
    Mammina C; Di Carlo P; Cipolla D; Casuccio A; Tantillo M; Plano MR; Mazzola A; Corsello G
    Acta Pharmacol Sin; 2008 Dec; 29(12):1486-92. PubMed ID: 19026168
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidemiology and clinical outcomes of patients with multiresistant Pseudomonas aeruginosa.
    Harris A; Torres-Viera C; Venkataraman L; DeGirolami P; Samore M; Carmeli Y
    Clin Infect Dis; 1999 May; 28(5):1128-33. PubMed ID: 10452647
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors for multidrug-resistant Pseudomonas aeruginosa nosocomial infection.
    Defez C; Fabbro-Peray P; Bouziges N; Gouby A; Mahamat A; Daurès JP; Sotto A
    J Hosp Infect; 2004 Jul; 57(3):209-16. PubMed ID: 15236849
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical surveillance of surgical imipenem-resistant Pseudomonas aeruginosa infection in a Japanese hospital.
    Sasaki M; Hiyama E; Takesue Y; Kodaira M; Sueda T; Yokoyama T
    J Hosp Infect; 2004 Feb; 56(2):111-8. PubMed ID: 15019222
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Poor clinical outcomes associated with a multi-drug resistant clonal strain of Pseudomonas aeruginosa in the Tasmanian cystic fibrosis population.
    Bradbury R; Champion A; Reid DW
    Respirology; 2008 Nov; 13(6):886-92. PubMed ID: 18811887
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nosocomial outbreak by imipenem-resistant metallo-beta-lactamase-producing Pseudomonas aeruginosa in an adult intensive care unit in a Brazilian teaching hospital.
    Cezário RC; Duarte De Morais L; Ferreira JC; Costa-Pinto RM; da Costa Darini AL; Gontijo-Filho PP
    Enferm Infecc Microbiol Clin; 2009 May; 27(5):269-74. PubMed ID: 19386392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fluoroquinolone-resistant Pseudomonas aeruginosa: risk factors for acquisition and impact on outcomes.
    Hsu DI; Okamoto MP; Murthy R; Wong-Beringer A
    J Antimicrob Chemother; 2005 Apr; 55(4):535-41. PubMed ID: 15728150
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of an alternative cefepime dosing strategy in pulmonary and bloodstream infections caused by Enterobacter spp, Citrobacter freundii, and Pseudomonas aeruginosa: a single-center, open-label, prospective, observational study.
    Deal EN; Micek ST; Reichley RM; Ritchie DJ
    Clin Ther; 2009 Feb; 31(2):299-310. PubMed ID: 19302902
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The influence of metallo-beta-lactamase production on mortality in nosocomial Pseudomonas aeruginosa infections.
    Zavascki AP; Barth AL; Gonçalves AL; Moro AL; Fernandes JF; Martins AF; Ramos F; Goldani LZ
    J Antimicrob Chemother; 2006 Aug; 58(2):387-92. PubMed ID: 16751638
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors for nosocomial infections due to Pseudomonas aeruginosa producing metallo-beta-lactamase in two tertiary-care teaching hospitals.
    Zavascki AP; Barth AL; Gaspareto PB; Gonçalves AL; Moro AL; Fernandes JF; Goldani LZ
    J Antimicrob Chemother; 2006 Oct; 58(4):882-5. PubMed ID: 16895936
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multidrug-resistant Pseudomonas aeruginosa bloodstream infections: risk factors and mortality.
    Tumbarello M; Repetto E; Trecarichi EM; Bernardini C; De Pascale G; Parisini A; Rossi M; Molinari MP; Spanu T; Viscoli C; Cauda R; Bassetti M
    Epidemiol Infect; 2011 Nov; 139(11):1740-9. PubMed ID: 21226988
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.